ESSENTIAL THROMBOCYTHEMIA (ET)
Clinical trials for ESSENTIAL THROMBOCYTHEMIA (ET) explained in plain language.
Never miss a new study
Get alerted when new ESSENTIAL THROMBOCYTHEMIA (ET) trials appear
Sign up with your email to follow new studies for ESSENTIAL THROMBOCYTHEMIA (ET), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cheap arthritis drug could be new weapon against rare blood cancers
Disease control Recruiting nowThis study tests whether low-dose methotrexate (MTX), a safe and inexpensive drug used for decades in arthritis, can help people with certain blood cancers called myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and myelofibrosis. Resea…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA (ET)
Phase: PHASE2 • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Disease control
Last updated May 26, 2026 12:12 UTC
-
Scientists hunt for immune clues to beat rare blood cancers
Knowledge-focused Recruiting nowThis study looks at how the immune system responds to myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect blood and bone marrow samples from 150 adults with MPN and healthy volunteers to find immune cells that recognize cancer cells. The g…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA (ET)
Sponsor: Université Catholique de Louvain • Aim: Knowledge-focused
Last updated May 26, 2026 12:10 UTC
-
New registry aims to unlock secrets of rare blood cancers
Knowledge-focused Recruiting nowThis study is a long-term registry for people with myeloproliferative neoplasms (MPNs), a group of rare blood cancers. Researchers will collect health records, surveys, and insurance data from 5,000 participants over at least five years to understand how the disease progresses an…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA (ET)
Sponsor: MPN Research Foundation • Aim: Knowledge-focused
Last updated May 26, 2026 12:09 UTC
-
Massive blood disease registry launches in china
Knowledge-focused Recruiting nowThis study is creating a large database of people with various blood diseases in China, such as leukemia, multiple myeloma, and hemophilia. Researchers will collect information from medical records and follow participants over time to learn about disease patterns, treatments, out…
Matched conditions: ESSENTIAL THROMBOCYTHEMIA (ET)
Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Knowledge-focused
Last updated May 26, 2026 12:07 UTC